Moderna COVID-19 vaccine: Continued monitoring
At the time of authorization, no major safety concerns have been reported in the available data submitted to Health Canada. We are carefully monitoring the post-market (after authorization) safety and effectiveness of authorized COVID-19 vaccines. As part of our commitment to keep Canadians informed, we are publishing information about adverse events following immunization (AEFI).
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-29
Data overview
- Formats
- HTML
- File languages
- English, French